{
   "source_x": "PMC",
   "title": "A decade after SARS: Strategies to control emerging coronaviruses",
   "doi": "http://dx.doi.org/10.1038/nrmicro3143",
   "pmcid": "PMC5147543",
   "abstract": "Two novel coronaviruses have emerged in humans in the 21(st) century, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome human coronavirus (MERS-CoV), both of which cause acute respiratory distress syndrome (ARDS) and have high mortality rates. There are no clinically approved vaccines or antiviral drugs available for either of these infections; thus, a priority in the field is the development of effective therapeutic and preventive strategies that can be readily applied to new emergent strains. This review will: describe the emergence and identification of novel human coronaviruses over the last 10 years; review their key biological features, including tropism and receptor use; and summarize approaches to develop broadly effective vaccines.",
   "authors": [
      "['Graham, Rachel L.', 'Donaldson, Eric F.', 'Baric, Ralph S.']"
   ],
   "id": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147543"
}